The Technical AnalystExchange: SIX Industry: Health Care Equipment & Services
Medartis Holding AG Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.25% CHF80.40
America/New_York / 2 mai 2024 @ 08:09
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 090.14 mill |
| EPS: | 0.0500 |
| P/E: | 1 608.00 |
| Earnings Date: | Mar 12, 2024 |
| SharesOutstanding: | 13.56 mill |
| Avg Daily Volume: | 0.0046 mill |
| RATING 2024-05-02 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 63.57x |
| Company: PE 1 608.00 | sector: PE 25.29 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 32.96x |
| Company: PE 1 608.00 | industry: PE 48.79 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CHF-13.08 (-116.27%) CHF-93.48 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
CHF 77.34 - 83.46 ( +/- 3.80%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | CHF80.40 (0.25% ) |
| Volume | 0.0003 mill |
| Avg. Vol. | 0.0046 mill |
| % of Avg. Vol | 6.16 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MED.SW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MED.SW
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.